{"id":925776,"date":"2026-01-09T07:30:42","date_gmt":"2026-01-09T12:30:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/"},"modified":"2026-01-09T07:30:42","modified_gmt":"2026-01-09T12:30:42","slug":"tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/","title":{"rendered":"Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BOSTON, Jan.  09, 2026  (GLOBE NEWSWIRE) &#8212; Tiziana Life Sciences, Ltd. (Nasdaq:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CdOo4Zb_CBwdSRXdHe4t3bAzoUWhLuhUMm7FmWk_S1upVXxNOzRoOfvKvFHIPcqthrjCz4quh-u6OJH2dM3mpsAp9tJQU9NFH3mgSf90pcAunx9IiD-OYfWECRhGOWK4\" rel=\"nofollow\" target=\"_blank\">TLSA<\/a>) (\u201cTiziana\u201d), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces that Chief Executive Officer Ivor Elrifi will deliver a corporate presentation at the 9th Annual Neuroscience Innovation Forum, organized by Sachs Associates. The presentation is scheduled for 2:00 PM PT on January 11, 2026, at the Marines&#8217; Memorial Club in San Francisco, California, during J.P. Morgan Healthcare Conference Week.<\/p>\n<p>Members of Tiziana&#8217;s senior management team will also attend the forum and be available for one-on-one meetings with investors, partners, and other stakeholders.<\/p>\n<p>The 9th Annual Neuroscience Innovation Forum is a premier industry event featuring keynotes, panel discussions, and company presentations focused on advances in therapeutics, neurotechnology, and diagnostics for neurological disorders. Tiziana&#8217;s presentation will highlight the Company&#8217;s lead candidate, intranasal foralumab, a fully human anti-CD3 monoclonal antibody designed to modulate the immune system and reduce microglial activation in neurodegenerative conditions.<\/p>\n<p>\u201cWe are excited to participate in this prestigious forum alongside leading innovators in neuroscience,\u201d said Ivor Elrifi, Chief Executive Officer of Tiziana Life Sciences. \u201cThis event provides an important platform to share updates on our clinical progress with intranasal foralumab and to engage with potential partners as we advance therapies for patients suffering from devastating diseases such as non-active secondary progressive multiple sclerosis and other neuroinflammatory conditions.\u201d<\/p>\n<p>\n        <strong>About Foralumab<\/strong>\n      <\/p>\n<p>Foralumab, a fully human anti-CD3 monoclonal antibody, is a biologic candidate that has been shown to stimulate T regulatory cells when dosed intranasally. Currently, 14 patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) have been dosed in an open-label intermediate sized Expanded Access (EA) Program (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=is26NufiRxBfKbKCVL6JF7GOJSBjJotQ6kkbDwo9x5E9zqOcwuwOIv5ggowkXqevhJdfTEFz2HZ5Z6RbVUlwligzTLz2jWWfo19ecJFgDuAnhVY51hgdZ_s1ltKL-j6Q\" rel=\"nofollow\" target=\"_blank\">NCT06802328<\/a>) with either an improvement or stability of disease seen within 6 months in all patients. In addition, intranasal foralumab is currently being studied in a Phase 2a, randomized, double-blind, placebo-controlled, multicenter, dose-ranging trial in patients with non-active secondary progressive multiple sclerosis (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=is26NufiRxBfKbKCVL6JF-eKTSU78v87aYEkl3mW-Ip6qM-IM0f7hGIDFKg61_sYI1hdNqepcxvM8uraM4VQ_aM7s4lntXr9hSOK1lkSITvOcN18gIkCWGNmaOTG3FH5\" rel=\"nofollow\" target=\"_blank\">NCT06292923<\/a>).<\/p>\n<p>Foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) currently in clinical development. Immunomodulation by intranasal foralumab represents a novel avenue for the treatment of neuroinflammatory and neurodegenerative human diseases.<sup>[1],[2]<\/sup><\/p>\n<p>\n        <strong>About Tiziana Life Sciences<\/strong>\n      <\/p>\n<p>Tiziana is a clinical-stage biopharmaceutical company developing breakthrough therapies using transformational drug delivery technologies to enable alternative routes of immunotherapy. Tiziana\u2019s innovative nasal approach has the potential to provide an improvement in efficacy as well as safety and tolerability compared to intravenous (IV) delivery. Tiziana\u2019s lead candidate, intranasal foralumab, which is the only fully human anti-CD3 mAb currently in clinical development, has demonstrated a favorable safety profile and clinical response in patients in studies to date. Tiziana\u2019s technology for alternative routes of immunotherapy has been patented with several applications pending and is expected to allow for broad pipeline applications.<\/p>\n<p>For more information about Tiziana and its innovative pipeline of therapies, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iJ2-Lv6OzCAMHukH_WuUztLRzWdSMczCVAjVfCSTUJUgZkPWMXr_sC-14EprBB9VoeHkBegnHdnQEQix0C7qk2NnxdemHFUhULfMA1weAytQ1lJiaXswNe35b281ZPkG\" rel=\"nofollow\" target=\"_blank\">www.tizianalifesciences.com<\/a>.<\/p>\n<p>\n        <strong>For further inquiries:<\/strong>\n      <\/p>\n<p>\n        <strong>Tiziana Life Sciences Ltd<\/strong><br \/>\n        <br \/>Paul Spencer, Business Development, and Investor Relations<br \/>+44 (0) 207 495 2379<br \/>email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4l_rKb2nBwAqia7_cO-yOUR1LjiHOsitKlDLx6D_xT5lqGGUCUM26P1R5UuBJS94mUJFsNqf3SLviF06-dcboRd_IDnfnVg-15Hd7RbJqjPnI79ARyQXkrmVuXfSjtub\" rel=\"nofollow\" target=\"_blank\">info@tizianalifesciences.com<\/a><\/p>\n<p>[1] <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6Pt0iUYeDHmYdNYt35uJmhIgktksKdDdLmoy138aoBzzDBabY0rT3KeAodd9zM5GCQRDFYMnyqeerlNv2ggvAoXu8fNkTcQp1Zi4-Tmd1w1j3nDtpNyc-PebuKM491wUn58k5YEiKkFOc6fZAF8btAj4uDiYJIvwkBaj1jcc-HA=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.pnas.org\/doi\/10.1073\/pnas.2220272120<\/a><br \/>[2]\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6Pt0iUYeDHmYdNYt35uJmhIgktksKdDdLmoy138aoBzzDBabY0rT3KeAodd9zM5Gpc5Lu9T8J3s6a2pmoqH0JYUktWGUJGObjw-kNtsx8_WuHZT_Ko6Dq5aUkwj1A7K1xS5w53QcfGh9Z9MO9sBcr9wH2L1-sN32qHWxpSfBOxc=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.pnas.org\/doi\/10.1073\/pnas.2309221120<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjM4NyM3MzUxNzAxIzIxMjM4ODU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YzIwZjY4N2QtZTczOC00ZTRmLTkwYmUtMWU5YjI4ZTcxZjYwLTExMzU0NTYtMjAyNi0wMS0wOS1lbg==\/tiny\/Tiziana-Life-Sciences-Plc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) &#8212; Tiziana Life Sciences, Ltd. (Nasdaq:\u00a0TLSA) (\u201cTiziana\u201d), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces that Chief Executive Officer Ivor Elrifi will deliver a corporate presentation at the 9th Annual Neuroscience Innovation Forum, organized by Sachs Associates. The presentation is scheduled for 2:00 PM PT on January 11, 2026, at the Marines&#8217; Memorial Club in San Francisco, California, during J.P. Morgan Healthcare Conference Week. Members of Tiziana&#8217;s senior management team will also attend the forum and be available for one-on-one meetings with investors, partners, and other stakeholders. The 9th Annual Neuroscience Innovation Forum is a premier industry event featuring keynotes, panel discussions, and company presentations focused &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-925776","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) &#8212; Tiziana Life Sciences, Ltd. (Nasdaq:\u00a0TLSA) (\u201cTiziana\u201d), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces that Chief Executive Officer Ivor Elrifi will deliver a corporate presentation at the 9th Annual Neuroscience Innovation Forum, organized by Sachs Associates. The presentation is scheduled for 2:00 PM PT on January 11, 2026, at the Marines&#8217; Memorial Club in San Francisco, California, during J.P. Morgan Healthcare Conference Week. Members of Tiziana&#8217;s senior management team will also attend the forum and be available for one-on-one meetings with investors, partners, and other stakeholders. The 9th Annual Neuroscience Innovation Forum is a premier industry event featuring keynotes, panel discussions, and company presentations focused &hellip; Continue reading &quot;Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-09T12:30:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjM4NyM3MzUxNzAxIzIxMjM4ODU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco\",\"datePublished\":\"2026-01-09T12:30:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\\\/\"},\"wordCount\":516,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjM4NyM3MzUxNzAxIzIxMjM4ODU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\\\/\",\"name\":\"Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjM4NyM3MzUxNzAxIzIxMjM4ODU=\",\"datePublished\":\"2026-01-09T12:30:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjM4NyM3MzUxNzAxIzIxMjM4ODU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjM4NyM3MzUxNzAxIzIxMjM4ODU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/","og_locale":"en_US","og_type":"article","og_title":"Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - Market Newsdesk","og_description":"BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) &#8212; Tiziana Life Sciences, Ltd. (Nasdaq:\u00a0TLSA) (\u201cTiziana\u201d), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces that Chief Executive Officer Ivor Elrifi will deliver a corporate presentation at the 9th Annual Neuroscience Innovation Forum, organized by Sachs Associates. The presentation is scheduled for 2:00 PM PT on January 11, 2026, at the Marines&#8217; Memorial Club in San Francisco, California, during J.P. Morgan Healthcare Conference Week. Members of Tiziana&#8217;s senior management team will also attend the forum and be available for one-on-one meetings with investors, partners, and other stakeholders. The 9th Annual Neuroscience Innovation Forum is a premier industry event featuring keynotes, panel discussions, and company presentations focused &hellip; Continue reading \"Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-09T12:30:42+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjM4NyM3MzUxNzAxIzIxMjM4ODU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco","datePublished":"2026-01-09T12:30:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/"},"wordCount":516,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjM4NyM3MzUxNzAxIzIxMjM4ODU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/","name":"Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjM4NyM3MzUxNzAxIzIxMjM4ODU=","datePublished":"2026-01-09T12:30:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjM4NyM3MzUxNzAxIzIxMjM4ODU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjM4NyM3MzUxNzAxIzIxMjM4ODU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tiziana-life-sciences-to-present-at-the-9th-annual-neuroscience-innovation-forum-during-j-p-morgan-healthcare-conference-week-in-san-francisco\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=925776"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925776\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=925776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=925776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=925776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}